Aelis Farma SA (AELIS.PA)
EUR 2.18
(2.83%)
EUR 2.18
(2.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -12.58 Million | -13.05 Million | 18.97 Million | -2.47 Million | -2.88 Million | -3.54 Million |
| Net Income | -5.07 Million | -14.28 Million | 574 Thousand | -2.08 Million | -3.17 Million | -2.7 Million |
| Depreciation & Amortization | 168 Thousand | 70 Thousand | 35 Thousand | 30 Thousand | 26 Thousand | 25 Thousand |
| Deferred income taxes | - | 4.38 Million | 2.19 Million | -832 Thousand | 163 Thousand | 74 Thousand |
| Stock-based compensation | 359 Thousand | 114 Thousand | 443 Thousand | 172 Thousand | 168 Thousand | 65 Thousand |
| Change in working capital | -7.67 Million | -3.4 Million | 16.38 Million | 116 Thousand | -183 Thousand | -1.09 Million |
| Other non-cash items | 337 Thousand | 74 Thousand | -656 Thousand | 122 Thousand | 109 Thousand | 84 Thousand |
| Investing Cash Flow | -88 Thousand | -86 Thousand | -212 Thousand | -34 Thousand | -36 Thousand | -15 Thousand |
| Investments in PPE | -88 Thousand | -137 Thousand | -213 Thousand | -35 Thousand | -36 Thousand | -18 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -88 Thousand | 51 Thousand | 1000.00 | 1000.00 | - | 3000.00 |
| Financing Cash Flow | -1.34 Million | 22.09 Million | 180 Thousand | 1.27 Million | 3.57 Million | 4.11 Million |
| Debt repayment | -347 Thousand | -23.25 Million | -307 Thousand | -1.34 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 127 Thousand | 25.54 Million | 35 Thousand | 2000.00 | 1.82 Million | 3.2 Million |
| Other Financing Activities | -994 Thousand | 19.8 Million | 452 Thousand | 2.61 Million | 1.75 Million | 915 Thousand |
| Accounts receivables | -677 Thousand | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.67 Million | -3.4 Million | 16.38 Million | 116 Thousand | - | - |
| Cash at beginning of period | 34.39 Million | 24.71 Million | 4.53 Million | 5.77 Million | 5.12 Million | 4.56 Million |
| Cash at end of period | 20.23 Million | 34.39 Million | 24.71 Million | 4.53 Million | 5.77 Million | 5.12 Million |
| Capital Expenditure | -88 Thousand | -137 Thousand | -213 Thousand | -35 Thousand | -36 Thousand | -18 Thousand |
| Effect of forex changes on cash | -170 Thousand | 723 Thousand | 1.23 Million | 2000.00 | 1000.00 | - |
| Net cash flow / Change in cash | -14.16 Million | 9.68 Million | 20.17 Million | -1.23 Million | 651 Thousand | 555 Thousand |
| Free Cash Flow | -12.67 Million | -13.18 Million | 18.75 Million | -2.51 Million | -2.92 Million | -3.56 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.79 Million | -1.79 Million | -1.72 Million | -5.07 Million | -1.72 Million | -1.63 Million |
| Depreciation & Amortization | 64 Thousand | 64 Thousand | 55.5 Thousand | 168 Thousand | 55.5 Thousand | 57 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 240.5 Thousand | 240.5 Thousand | 116.5 Thousand | 359 Thousand | 116.5 Thousand | 63 Thousand |
| Change in working capital | -2.17 Million | -2.17 Million | -1.64 Million | -7.67 Million | -1.64 Million | -4.39 Million |
| Other non-cash items | -429.5 Thousand | -429.5 Thousand | 733 Thousand | 337 Thousand | 733 Thousand | -1.84 Million |
| Investing Cash Flow | -82.5 Thousand | -82.5 Thousand | -73.5 Thousand | -88 Thousand | -73.5 Thousand | -82 Thousand |
| Investments in PPE | -82.5 Thousand | -82.5 Thousand | -3000.00 | -88 Thousand | -3000.00 | -82 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -70.5 Thousand | -88 Thousand | -70.5 Thousand | 70.5 Thousand |
| Financing Cash Flow | 359.5 Thousand | 359.5 Thousand | -576.5 Thousand | -1.34 Million | -576.5 Thousand | -781 Thousand |
| Debt repayment | -873 Thousand | - | -220 Thousand | -347 Thousand | - | -567 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -57.5 Thousand | - | -57.5 Thousand | - |
| Common Stock Issuance | - | - | -115 Thousand | 127 Thousand | - | 115 Thousand |
| Other Financing Activities | 359.5 Thousand | 359.5 Thousand | -576.5 Thousand | -994 Thousand | -576.5 Thousand | -300 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.17 Million | -2.17 Million | -1.64 Million | -7.67 Million | -1.64 Million | -4.39 Million |
| Cash at beginning of period | 20.23 Million | - | 25.45 Million | 34.39 Million | 500 Thousand | 34.39 Million |
| Cash at end of period | 12.58 Million | -3.81 Million | 20.23 Million | 20.23 Million | -2.61 Million | 25.45 Million |
| Capital Expenditure | -82.5 Thousand | -82.5 Thousand | -3000.00 | -88 Thousand | -3000.00 | -82 Thousand |
| Effect of forex changes on cash | -2000.00 | -2000.00 | -10.5 Thousand | -170 Thousand | -10.5 Thousand | -74.5 Thousand |
| Net cash flow / Change in cash | -7.64 Million | -3.81 Million | -5.22 Million | -14.16 Million | -3.11 Million | -8.94 Million |
| Free Cash Flow | -4.17 Million | -4.17 Million | -2.46 Million | -12.67 Million | -2.46 Million | -8.01 Million |
0236
HTLD
605277
TULIVE
TGNT
PAYTM